Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Apelqvist

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Behavioural Brain Research|July 11, 1998
Diurnal and gender effects by chronic portacaval shunting in rats on spontaneous locomotor and rearing activities in an open-fieldG Apelqvist, B Hindfelt, G Andersson, et al.
Physiology & Behavior|June 1, 1997
Central vs. peripheral spontaneous behavioral abnormalities in experimental hepatic encephalopathyG Apelqvist, B Hindfelt, G Andersson, et al.
Behavioural Brain Research|December 14, 1999
Altered adaptive behaviour expressed in an open-field paradigm in experimental hepatic encephalopathyG Apelqvist, B Hindfelt, G Andersson, et al.
Metabolic Brain Disease|September 1, 1996
Acute effects of L-tryptophan on brain extracellular 5-HT and 5-HIAA levels in chronic experimental portal-systemic encephalopathyP B Bergqvist, S Hjorth, G Apelqvist, et al.
Metabolic Brain Disease|November 5, 1997
Potassium-evoked neuronal release of serotonin in experimental chronic portal-systemic encephalopathyP B Bergqvist, S Hjorth, G Apelqvist, et al.
Pharmacology & Toxicology|October 16, 1999
Plasma and brain levels of oxindole in experimental chronic hepatic encephalopathy: effects of systemic ammonium acetate and L-tryptophanP B Bergqvist, R Carpenedo, G Apelqvist, et al.
Clinical Neuropharmacology|January 22, 2002
Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathyC Wikell, F C Kugelberg, S Hjorth, et al.
Clinical Neuropharmacology|December 24, 1997
Effect of citalopram on brain serotonin release in experimental hepatic encephalopathy: implications for thymoleptic drug safety in liver insufficiencyP B Bergqvist, C Wikell, S Hjorth, et al.
Acta Physiologica Scandinavica|May 23, 1998
Regional brain serotonin receptor changes in portacaval shunted ratsG Apelqvist, P B Bergqvist, B Larsson, et al.
British Journal of Pharmacology|April 20, 2001
In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to ratsF C Kugelberg, G Apelqvist, B Carlsson, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Behavioural Brain Research|July 11, 1998
Diurnal and gender effects by chronic portacaval shunting in rats on spontaneous locomotor and rearing activities in an open-fieldG Apelqvist, B Hindfelt, G Andersson, et al.
Physiology & Behavior|June 1, 1997
Central vs. peripheral spontaneous behavioral abnormalities in experimental hepatic encephalopathyG Apelqvist, B Hindfelt, G Andersson, et al.
Behavioural Brain Research|December 14, 1999
Altered adaptive behaviour expressed in an open-field paradigm in experimental hepatic encephalopathyG Apelqvist, B Hindfelt, G Andersson, et al.
Metabolic Brain Disease|September 1, 1996
Acute effects of L-tryptophan on brain extracellular 5-HT and 5-HIAA levels in chronic experimental portal-systemic encephalopathyP B Bergqvist, S Hjorth, G Apelqvist, et al.
Metabolic Brain Disease|November 5, 1997
Potassium-evoked neuronal release of serotonin in experimental chronic portal-systemic encephalopathyP B Bergqvist, S Hjorth, G Apelqvist, et al.
Pharmacology & Toxicology|October 16, 1999
Plasma and brain levels of oxindole in experimental chronic hepatic encephalopathy: effects of systemic ammonium acetate and L-tryptophanP B Bergqvist, R Carpenedo, G Apelqvist, et al.
Clinical Neuropharmacology|January 22, 2002
Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathyC Wikell, F C Kugelberg, S Hjorth, et al.
Clinical Neuropharmacology|December 24, 1997
Effect of citalopram on brain serotonin release in experimental hepatic encephalopathy: implications for thymoleptic drug safety in liver insufficiencyP B Bergqvist, C Wikell, S Hjorth, et al.
Acta Physiologica Scandinavica|May 23, 1998
Regional brain serotonin receptor changes in portacaval shunted ratsG Apelqvist, P B Bergqvist, B Larsson, et al.
British Journal of Pharmacology|April 20, 2001
In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to ratsF C Kugelberg, G Apelqvist, B Carlsson, et al.
Pageof 3